Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Type C Meeting Timings

<< Previous

Bullboard Posts

Next >>

Comment by jh1970on Apr 11, 2024 6:45pm

94 Views

Post# 35984467

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings

Yes, it is a shame. It is a shame that I believed managment which keep me at dark and always is finding new excuse to change previous plan of delivering pela to the market. I belive in Pela that can make miracles and hope that some day in the future Pela will be on the market as a cure for all sick people , but I doubt that this managment will do it.

Azzak34, I know I sound pesimistic and I`m very critical ,specially about way this managment is doing busines with shareholders,
but I never called other people IDIOT.
Try to understand other people before you open your mouth.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?